| 11813306 |
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders |
Brian Addison DECHRISTOPHER, Alec Nathanson Flyer, Andrei Golosov, Philipp Grosche, Eugene Yuejin Liu +6 more |
2023-11-14 |
$118,408,000 |
| 11026993 |
Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders |
Brian Addison DECHRISTOPHER, Alec Nathanson Flyer, Andrei Golosov, Philipp Grosche, Eugene Yuejin Liu +7 more |
2021-06-08 |
$23,526,000 |
| 8580780 |
6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonist |
John Gordon Allen, Christopher Stanley Galka, Maria Angeles Martinez-Grau, Matthew Robert Reinhard, Michael Rodriguez +9 more |
2013-11-12 |
$216,055,000 |
| 8420631 |
6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
John Gordon Allen, Anne Marie Camp, Manuel Javier Cases-Thomas, Richard C. Hoying, Maria Angeles Martinez-Grau +6 more |
2013-04-16 |
$124,968,000 |
| 8022062 |
6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
John Gordon Allen, Michael Philip Cohen, Christopher Stanley Galka, Sarah Lynne Hellman, Maria Angeles Martinez-Grau +8 more |
2011-09-20 |
$59,131,000 |
| 7994163 |
6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
John Gordon Allen, Christopher Stanley Galka, Richard C. Hoying, Maria Angeles Martinez-Grau, Julie M. Miyashiro +2 more |
2011-08-09 |
$42,609,000 |
| 7981882 |
6-N-linked heterocycle-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
Anne Marie Camp, Alan Cornell, Michael Philip Mazanetz, Roger Ryan Rothhaar, Frantz Victor +2 more |
2011-07-19 |
$50,826,000 |
| 7291619 |
Melanocortin receptor agonists |
Christopher Kelly Biggers, Christopher William Doecke, Matthew Joseph Fisher, Larry W. Hertel, Vincent Mancuso +8 more |
2007-11-06 |
$65,050,000 |
| 7186715 |
Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
Christopher William Doecke, Vincent Mancuso, Michael John Martinelli, Timothy Ivo Richardson, Roger Ryan Rothhaar +2 more |
2007-03-06 |
$170,937,000 |
| 7169777 |
Melanocortin receptor agonists |
Ryan Thomas Backer, Ivan Collado Cano, Oscar De Frutos Garcia, Christopher William Doecke, Matthew Joseph Fisher +9 more |
2007-01-30 |
$96,817,000 |
| 7157463 |
Substituted piperidines/piperazines as melanocortin receptor agonists |
Ryan Thomas Backer, Christopher William Doecke, Matthew Joseph Fisher, Steven Lee Kuklish, Vincent Mancuso +3 more |
2007-01-02 |
|
| 7045545 |
Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists |
Joseph P. Burkhart, Timothy Paul Burkholder, Matthew Joseph Fisher, William Harlan Gritton, Daniel Timothy Kohlman +5 more |
2006-05-16 |
$105,956,000 |
| 6967201 |
Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
Joseph P. Burkhart, Timothy Paul Burkholder, Brian Eugene Cunningham, Matthew Joseph Fisher, William Harlan Gritton +6 more |
2005-11-22 |
$247,860,000 |
| 6881733 |
Serotonergic benzofurans |
Joseph P. Burkhart, Timothy Paul Burkholder, Brian Eugene Cunningham, Matthew Joseph Fisher, William Harlan Gritton +9 more |
2005-04-19 |
$326,874,000 |
| 6638936 |
Benzofurylpiperazine serotonin agonists |
Timothy Paul Burkholder, Mark L. Heiman, David L. Nelson |
2003-10-28 |
$145,966,000 |
